<DOC>
	<DOCNO>NCT02249728</DOCNO>
	<brief_summary>The purpose study investigate test drug , PBT2 , take , broken remove body give oral capsule , radiolabelled oral suspension radiolabelled intravenous injection .</brief_summary>
	<brief_title>Absorption , Metabolism Excretion Study 14CPBT2 Absolute Bioavailability PBT2</brief_title>
	<detailed_description />
	<criteria>Healthy male Body mass index 18.0 35.0 kg/m2 History drug alcohol abuse past 2 year Regular alcohol consumption &gt; 21 unit per week ( 1 unit = Â½ pint beer , 25 mL 40 % spirit 125 mL glass wine ) Current smoker smoke within last 12 month Radiation exposure , include present study , exclude background radiation include diagnostic xrays medical exposure , exceed 5 mSv last 12 month 10 mSv last 5 year . Clinically significant abnormal biochemistry , haematology urinalysis judge investigator Positive drug abuse test result Positive hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( HCV Ab ) human immunodeficiency virus ( HIV ) result History cardiovascular , renal , hepatic , chronic respiratory GI disease judge investigator</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>